99mTc-3PRGD2 SPECT/CT imaging agent

99mTc-3PRGD2 · RDO Pharm

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 99mTc-3PRGD2 SPECT/CT imaging agent, covering 2024-07-01 to 2024-07-01. Get the full timeline:

Most recent: Clinical Trial Update: 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer [Phase 3]